Monthly Recurring Revenue (MRR)HealthTechSeries C
Monthly Recurring Revenue (MRR) for HealthTech at Series C (Advertising)
2026 data · Sample size: 383 · Source: KeyBanc SaaS Survey 2026
25th %ile
$52,174
Median
$81,521
75th %ile
$105,978
90th %ile
$125,543
▲Trending up year-over-year
About This Metric
Predictable monthly revenue from all active subscriptions, normalized to a monthly figure.
Sum of all monthly subscription revenue
Higher is better · Unit: currency
How to Improve
Focus on net-new logo velocity and expansion within existing accounts. Implement annual contracts with upfront payment discounts. Build a predictable pipeline with 3x coverage.
Ehsan's Analysis
Series C-stage HealthTech companies obsess over MRR growth rate but ignore composition. Net-new vs expansion vs reactivation tells the real story. The healthiest companies I work with get 35%+ of MRR growth from expansion, not new logos. If your expansion revenue is below 20% of total growth, you have a retention problem wearing a growth costume.
EJ
Ehsan Jahandarpour
AI Growth Strategist & Fractional CMO
Forbes Top 20 Growth Hacker · TEDx Speaker · 716 Academic Citations · Ex-Microsoft · CMO at FirstWave (ASX:FCT) · Forbes Communications Council
Frequently Asked Questions
What is a good Monthly Recurring Revenue (MRR) for HealthTech at Series C?
The median Monthly Recurring Revenue (MRR) is $81,521. Top-quartile companies achieve $105,978. Aim for top-quartile to be competitive.
How does Monthly Recurring Revenue (MRR) change by company stage?
Monthly Recurring Revenue (MRR) improves as companies mature. Later-stage companies benefit from scale and optimization.
How to improve Monthly Recurring Revenue (MRR) in HealthTech?
Focus on the primary drivers specific to HealthTech. Track weekly with a 4-week rolling average and iterate on the biggest lever.